BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 18494756)

  • 1. Employee and Employer Benefits From a Migraine Management Program: Disease Outcomes and Cost Analysis.
    Schaetz L; Rimner T; Pathak P; Fang J; Chandrasekhar D; Mueller J; Sandor PS; Gantenbein AR
    Headache; 2020 Oct; 60(9):1947-1960. PubMed ID: 32799346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing migraine self-efficacy and reducing disability through a self-management program.
    Short AL
    J Am Assoc Nurse Pract; 2019 Nov; 33(1):20-28. PubMed ID: 31738274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome measures for migraine: Measuring the impact of migraine and results of migraine treatment.
    Hareendran A; Mannix S
    Handb Clin Neurol; 2024; 199():303-328. PubMed ID: 38307654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study.
    Pascual J; Panni T; Dell'Agnello G; Gonderten S; Novick D; Evers S
    J Headache Pain; 2023 Oct; 24(1):142. PubMed ID: 37864166
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1
    Schwedt TJ; Tassorelli C; Silberstein SD; Szperka CL; Kurth T; Pozo-Rosich P; Amin FM; Lipton RB; Dodick DW; Ashina M; Diener HC; Terwindt GM
    Cephalalgia; 2022 Oct; 42(11-12):1099-1115. PubMed ID: 35514209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient-centered outcome.
    Lipton RB; Dodick DW; Ailani J; McGill L; Hirman J; Cady R
    Headache; 2021 May; 61(5):766-776. PubMed ID: 34013992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the impact of headaches and the outcomes of treatment: A systematic review of patient-reported outcome measures (PROMs).
    Haywood KL; Mars TS; Potter R; Patel S; Matharu M; Underwood M
    Cephalalgia; 2018 Jun; 38(7):1374-1386. PubMed ID: 28920448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric evaluation of a multi-dimensional measure of satisfaction with behavioral interventions.
    Sidani S; Epstein DR; Fox M
    Res Nurs Health; 2017 Oct; 40(5):459-469. PubMed ID: 28857205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
    Goadsby PJ
    Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability.
    Stewart WF; Lipton RB; Dowson AJ; Sawyer J
    Neurology; 2001; 56(6 Suppl 1):S20-8. PubMed ID: 11294956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further validation of an individualized migraine treatment satisfaction measure.
    Martin ML; Patrick DL; Bushnell DM; Gandra SR; Gilchrist K
    Value Health; 2008; 11(5):904-12. PubMed ID: 18494756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring satisfaction with migraine treatment: expectations, importance, outcomes, and global ratings.
    Patrick DL; Martin ML; Bushnell DM; Pesa J
    Clin Ther; 2003 Nov; 25(11):2920-35. PubMed ID: 14693316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.
    Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D; Kilminster S
    Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire.
    Ertaş M; Siva A; Dalkara T; Uzuner N; Dora B; Inan L; Idiman F; Sarica Y; Selçuki D; Sirin H; Oğuzhanoğlu A; Irkeç C; Ozmenoğlu M; Ozbenli T; Oztürk M; Saip S; Neyal M; Zarifoğlu M;
    Headache; 2004 Sep; 44(8):786-93. PubMed ID: 15330825
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.